Literature DB >> 32646456

Transpulmonary pressure in SARS-CoV-2-associated acute respiratory distress syndrome: a single-center observational study.

Severin Ramin1,2, Jonathan Charbit3,4, Geoffrey Dagod3,4, Mehdi Girard3,4, Samir Jaber5,6, Xavier Capdevila3,4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32646456      PMCID: PMC7347254          DOI: 10.1186/s13054-020-03129-5

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
Dear Editor, Gattinoni et al. [1] have recently described that the ARDS related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was not a “typical” ARDS. Patients indeed presented a significant hypoxemia, which was surprisingly associated with a high compliance of the respiratory system. The cornerstone of current treatment is the use of “lung protective” ventilation strategy with especially maintaining sufficiently high positive end-expiratory pressures (PEEP). However, high levels of PEEP may lead to lung overdistension associated with an increase of alveolar dead space and an alteration of gas exchanges. The airway pressures commonly monitored on respirators do not reliably reflect the impact of pressures on the lung parenchyma. In contrast, transpulmonary pressures allow to highlight directly lung overdistension risk and lung properties. In order to better know this new kind of ARDS, transpulmonary pressures’ assessment seems to be essential [2]. We wish to report the preliminary findings of a prospective monocentric physiological work, which is approved by the institutional ethics review board of the Montpellier University Hospital, France (IRB ID: 202000432). All consecutive ARDS adult patients with confirmed Covid-19 admitted in our critical care unit are included if they received invasive mechanical. Management of patients followed international recommendations. PEEP was set according to the low PEEP arm of the PEEP/FiO2 table used in previous trials. Esophageal pressures were recorded with Cooper Surgical® device. Sixteen patients were assessed (body mass index 29 [range 26–31] kg/m2, age 70 years [range 61–72 years]). The median worst value of PaO2/FiO2 ratio was 144 mmHg [range 138–149 mmHg]. Baseline of patient characteristics may be observed in the Table 1. Six patients received at least one session of prone positioning. One of them also benefited from VV-ECMO. We observed that median transpulmonary end-expiratory pressure was positive during mechanical ventilation (2 cm H2O at D1 [range − 1–3 cm H2O]) and median transpulmonary elastance (EL) remained low at day 1 (19 cm H2O/L [range 8–20 cm H2O/L]) and during the first week. All our findings are shown in Fig. 1.
Table 1

Baseline characteristics of the patients and respiratory mechanics (n = 16)

Characteristics
 Male, n (%)11 (69)
 Age (years)70 (61–72)
 Body mass index (kg/m2)29 (26–31)
 Organ failure at baseline (SOFA), n (%)
  Hemodynamic12 (75)
  Renal4 (25)
  Hepatic2 (13)
  Hematological1 (6)
 Arterial blood gas
  PaO2/FiO2 ratio170 (150–208)
  pH7.43 (7.38–7.47)
  PaO2 (mmHg)71 (62–89)
  PaCO2 (mmHg)40 (37–45)
  Lactates (mmol/l)1.2 (1–1.4)
 Radiologic characteristics, n (%)
  Bilateral pneumonia4 (25)
  Multiple mottling and ground-glass opacity12 (75)
 Time between admission and intubation (day)2 (2–3)
Respiratory mechanics at day 1
 Tidal volume (ml/kg PBW)7 (6.6–7.3)
 Respiratory rate (beats/min)22 (20–24)
 PEEPtot,rs (cm H2O)10 (10–13)
 PEEPtot,es (cm H2O)8 (8–12)
 PEEPtot,L (cm H2O)2 (−1–3)
 Pplat,rs (cm H2O)19 (18–22)
 Pplat,es (cm H2O)13 (11–16)
 Pplat,L (cm H2O)6 (6–11)
 DP,rs (cm H2O)9 (6–12)
 DP,cw (cm H2O)5 (3–5)
 DP,L (cm H2O)4 (2–9)
 Est,rs (cm H2O/L)23 (18–30)
 Est,cw (cm H2O/L)4 (4–10)
 Est,L (cm H2O/L)19 (8–20)

Results are expressed as median (IQR) or as number of patients (percentage) as appropriate

PBW, predicted body weight; SOFA, sepsis-related organ failure; PEEPtot,rs, static end-expiratory pressure of the respiratory system; PEEPtot,es, static end-expiratory esophageal pressure; PEEPtot,L, static end-expiratory transpulmonary pressure; Pplat,rs, static end-inspiratory pressure of the respiratory system; Pplat,es, static end-inspiratory esophageal pressure; Pplat,L, static end-inspiratory transpulmonary pressure; DP,rs, DP,cw, DP,L, driving pressure of respiratory system, chest wall, and lung, respectively; Est,rs, Est,cw, Est,L, static elastance of respiratory system, chest wall, and lung, respectively

Fig. 1

Respiratory physiological measures during mechanical ventilation. Boxes represent median and interquartile range. The number of patients with available respiratory physiological data decreases over successive study days due to deaths and discontinuation of invasive mechanical ventilation. Transpulmonary pressure (PL) equals respiratory system pressure minus esophageal pressure. Respiratory system driving pressure equals plateau pressure minus positive end expiratory pressure (PEEP). Transpulmonary driving pressure equals end-inspiratory PL minus end-expiratory PL

Baseline characteristics of the patients and respiratory mechanics (n = 16) Results are expressed as median (IQR) or as number of patients (percentage) as appropriate PBW, predicted body weight; SOFA, sepsis-related organ failure; PEEPtot,rs, static end-expiratory pressure of the respiratory system; PEEPtot,es, static end-expiratory esophageal pressure; PEEPtot,L, static end-expiratory transpulmonary pressure; Pplat,rs, static end-inspiratory pressure of the respiratory system; Pplat,es, static end-inspiratory esophageal pressure; Pplat,L, static end-inspiratory transpulmonary pressure; DP,rs, DP,cw, DP,L, driving pressure of respiratory system, chest wall, and lung, respectively; Est,rs, Est,cw, Est,L, static elastance of respiratory system, chest wall, and lung, respectively Respiratory physiological measures during mechanical ventilation. Boxes represent median and interquartile range. The number of patients with available respiratory physiological data decreases over successive study days due to deaths and discontinuation of invasive mechanical ventilation. Transpulmonary pressure (PL) equals respiratory system pressure minus esophageal pressure. Respiratory system driving pressure equals plateau pressure minus positive end expiratory pressure (PEEP). Transpulmonary driving pressure equals end-inspiratory PL minus end-expiratory PL Many reports have highlighted specificities of SARS-CoV-2, particularly that the elastance of respiratory system (ERS) was slightly altered. Driving pressures of the respiratory system are therefore quite low in these patients. Unsurprisingly, our study showed that the E was not elevated in the first days of mechanical ventilation. The main finding of the present work is that end-expiratory transpulmonary pressure remained positive in most patients with the use of moderate PEEP (8–13 cm H2O). To summarize, our analysis is in agreement with the descriptions of Gattinoni et al. [3]. Most of these patients present indeed low ERS, low ventilation to perfusion ratio (VA/Q), and low lung recruitability due to the low amount of non-aerated tissue (L profile). Hypoxemia and intrapulmonary shunt might thus be better explained by dysregulation of pulmonary perfusion and by alteration of hypoxic vasoconstriction. This would justify the use of moderate levels of PEEP to limit alveolar dead space and optimize the CO2 removal. Gattinoni et al. [4] also described that 20–30% of patients presented a delayed aggravation with more usual pulmonary parameters: high ERS, high right-to-left shunt, high lung recruitability (H profile). Constitution of atelectasis or bacterial overinfection is associated with H profile. This is observable in our series since a part of patients experienced an increase of ERS as EL (Fig. 1c). For the latter, elevated PEEP seems to be more legitimate [5]. To conclude, identification of respiratory phenotype seems therefore essential in ventilated SARS-CoV-2 patients to determine optimal mechanical ventilation strategy. Our observations support the concept of using low PEEP in a large part of SARS-CoV-2 patients.
  4 in total

Review 1.  Targeting transpulmonary pressure to prevent ventilator-induced lung injury.

Authors:  Luciano Gattinoni; Lorenzo Giosa; Matteo Bonifazi; Iacopo Pasticci; Mattia Busana; Matteo Macri; Federica Romitti; Francesco Vassalli; Michael Quintel
Journal:  Expert Rev Respir Med       Date:  2019-07-05       Impact factor: 3.772

2.  COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.

Authors:  Luciano Gattinoni; Silvia Coppola; Massimo Cressoni; Mattia Busana; Sandra Rossi; Davide Chiumello
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

3.  COVID-19 pneumonia: ARDS or not?

Authors:  Luciano Gattinoni; Davide Chiumello; Sandra Rossi
Journal:  Crit Care       Date:  2020-04-16       Impact factor: 9.097

4.  COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Authors:  Luciano Gattinoni; Davide Chiumello; Pietro Caironi; Mattia Busana; Federica Romitti; Luca Brazzi; Luigi Camporota
Journal:  Intensive Care Med       Date:  2020-04-14       Impact factor: 17.440

  4 in total
  2 in total

1.  Effects of non-invasive respiratory supports on inspiratory effort in moderate-severe COVID-19 patients. A randomized physiological study.

Authors:  Gioacchino Schifino; Maria L Vega; Lara Pisani; Irene Prediletto; Vito Catalanotti; Vittoria Comellini; Ilaria Bassi; Maurizio Zompatori; Marco Vito Ranieri; Stefano Nava
Journal:  Eur J Intern Med       Date:  2022-04-22       Impact factor: 7.749

2.  The Pathophysiology and Dangers of Silent Hypoxemia in COVID-19 Lung Injury.

Authors:  Kai E Swenson; Stephen J Ruoss; Erik R Swenson
Journal:  Ann Am Thorac Soc       Date:  2021-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.